Clinical observation of Sangxingqingfeitang joint Montelukast in treatment of children with cough variant asthma
LU Miaoyun
Abstract
LU Miaoyun
Abstract
Objective To observe the effect of Sangxingqingfeitang joint Montelukast in Children with cough variant asthma.Methods One hundred cases of children with cough variant asthma were randomly divided into treatment group and control group.Sangxingqingfeitang joint Montelukast was administered to 50 patients in treatment group,the routine therapy was given to 50 patients in control group for 3 months,the follow-up was 1 year.Results In treatment group,46 cases (92%) were cured;2 patients (4%) demonstrated to be marked improvement;2 patients (4%) with improvement;0 patient (0%) with no response;the total rate of effects was 100%.In control group,33 cases (66%) were cured;4 patients (8%) demonstrated to be marked improvement;4 patients (8%) with improvement;9 patients (18%) with no response;the total rate of effects was 82%.There was significant difference in total rate of effects between two groups.Conclusion The treatment of Sangxinqingfei Tang joint Montelukast in children with cough variant asthma has high efficiency,is worthy to recommending in clinical use.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the effect of Sangxingqingfeitang joint Montelukast in Children with cough variant asthma.Methods One hundred cases of children with cough variant asthma were randomly divided into treatment group and control group.Sangxingqingfeitang joint Montelukast was administered to 50 patients in treatment group,the routine therapy was given to 50 patients in control group for 3 months,the follow-up was 1 year.Results In treatment group,46 cases (92%) were cured;2 patients (4%) demonstrated to be marked improvement;2 patients (4%) with improvement;0 patient (0%) with no response;the total rate of effects was 100%.In control group,33 cases (66%) were cured;4 patients (8%) demonstrated to be marked improvement;4 patients (8%) with improvement;9 patients (18%) with no response;the total rate of effects was 82%.There was significant difference in total rate of effects between two groups.Conclusion The treatment of Sangxinqingfei Tang joint Montelukast in children with cough variant asthma has high efficiency,is worthy to recommending in clinical use.
Key concepts: Medicine, Montelukast, Asthma, Treatment and control groups, Clinical efficacy, Anesthesia, Significant difference, Internal medicine